Study skin microbiome changes in early mycosis fungoides
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This early-phase study tests a spray solution (APR-TD011®) for people with early-stage mycosis fungoides and looks at how the bacteria on the skin change before and after treatment. It may help researchers understand whether the spray improves the skin environment that can affect this lymphoma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re an adult with early-stage mycosis fungoides (stages IA or IB).
- You have at least two skin spots (lesions) that have been there for 3+ weeks, and the combined area is at least 10 square centimeters.
- At least one target spot must have a swab test that grows Staphylococcus aureus (a common skin bacteria).
- You can’t use antibiotics right now, and you haven’t used topical or oral/systemic antibiotics in the past 4 weeks.
- Before each study visit, you’ll avoid washing or putting anything on the target spot starting the night before.
- During the study, you must avoid bleach or vinegar baths and other antiseptic products on the target spot.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special skin care body wash can improve skin lesions in people with mycosis fungoides, a type of skin lymphoma. Researchers will look at skin bacteria before and after using the wash.
This study looks at the bacteria (microbiome) living on the skin in people with specific skin conditions, and in healthy volunteers. The results may help researchers understand what skin microbes have to do with these diseases.
This trial tests a cream applied to the skin that may help control early-stage mycosis fungoides, a type of skin lymphoma. It aims to see if the cream can reduce symptoms and slow disease progression without the need for stronger treatments.
This trial tests a treatment called photopheresis to treat early-stage mycosis fungoides, a type of skin lymphoma. It may help reduce or control skin patches or plaques that have not responded well to standard treatments.
This Phase 1 study tests whether the medicine bexarotene combined with radiotherapy can shrink or control mycosis fungoides, a skin lymphoma. It also looks at how safe the combination is and how the body handles the treatment.
This trial tests a cream containing duvelisib, a drug that may help treat the skin patches of early-stage mycosis fungoides, a type of skin lymphoma. The cream is applied directly to the affected skin to see if it can control the disease.
Hear when a new Cutaneous T Cell Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.